Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Brain-selective potassium channel ligands synthesized at Bayer

June 19, 1998

FDA accepts IND to test ADL-2-1294 for relief of corneal pain

June 19, 1998

Melatonin effective therapy for headache in patients with sleep phase delay syndrome

June 18, 1998

Guilford offering two lead neuroprotective programs for licensing

June 18, 1998

MitoKor and UCSF collaborate on Alzheimer's disease research

June 18, 1998

Memric development on hold, SKB says

June 17, 1998

CGRP receptor antagonists developed at SKB

June 17, 1998

Scientists uncover genetic mutations responsible for hereditary form of dementia

June 17, 1998

CytoTherapeutics and Astra resume phase IIb clinical trial of pain control implant

June 16, 1998

Nippon Suisan isolates the first trisubstituted alkyl phenol antioxidant from a fungal source

June 16, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...